Related references
Note: Only part of the references are listed.A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Lung Metastasis Fails in MMTV-PyMT Oncomice Lacking S100A4 Due to a T-Cell Deficiency in Primary Tumors
Birgitte Grum-Schwensen et al.
CANCER RESEARCH (2010)
Cancer metastasis as a therapeutic target
Jonathan Sleeman et al.
EUROPEAN JOURNAL OF CANCER (2010)
Different Expression and Clinical Role of S100A4 in Serous Ovarian Carcinoma at Different Anatomic Sites
Gunhild M. Maelandsmo et al.
TUMOR BIOLOGY (2009)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Expression of S100A4 by, a variety of cell types present in the tumor microenvironment of human breast cancer
Teresa Cabezon et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
The metastasis associated protein S100A4: role in tumour progression and metastasis
DM Helfman et al.
BRITISH JOURNAL OF CANCER (2005)
Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene
B Grum-Schwensen et al.
CANCER RESEARCH (2005)
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer
S Suwiwat et al.
CLINICAL CANCER RESEARCH (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin
Y Hamano et al.
CANCER CELL (2003)
A molecular signature of metastasis in primary solid tumors
S Ramaswamy et al.
NATURE GENETICS (2003)
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
F Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts
M Iwano et al.
MOLECULAR THERAPY (2001)
Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer
KF Chin et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
